Fewer than half of us finish an antibiotic course.
The recommended treatment after confirmed exposure to anthrax is a combination of a vaccine and antibiotics because anthrax spores are so hardy they can outlive the 60-day antibiotic course and still possibly threaten an exposed person.
But the panel noted that, were a vaccine available, the antibiotic course could be ended after just a month if the patient were to be vaccinated immediately after exposure.
Inclusion criteria were: age between 18 and 75 years, at least 1 year post SCI, experience of at least three symptomatic UTIs requiring an antibiotic course of treatment within the previous 12 months and ability to provide informed consent.
In most cases, the pathogen responsible for triggering the septic condition is never pinpointed, so clinicians blindly prescribe an antibiotic course in a blanket attempt to stave off infectious bacteria and halt the body's dangerous inflammatory response.
But last week, in an article in the Medical Journal of Australia, Professor Gwendolyn Gilbert of the University of Sydney wrote: "There is a common misconception that resistance will emerge if a prescribed antibiotic course is not completed".
A pan-European market research study of 3254 patients designed to determine patient attitudes, expectations and behaviour to antibiotic management of mild moderate RTIs, identified three key drivers of perceived antibiotic efficacy: length of antibiotic course, time to onset of symptom relief and time to complete resolution of symptoms.
At one month follow-up, the patient reported resolution of symptoms after the antibiotic course.
Their limited outcome findings indicate success rate of 87.3% antibiotic course completion.
Two days after his antibiotic course was completed, the patient presented with redness and right eye pain.
Immunotherapy initiated at the outset of an antibiotic course has the potential to result in beneficial effects; however, use is frequently limited by a narrow spectrum of action against specific target antigens.
